331.74
price up icon2.02%   6.56
after-market Handel nachbörslich: 331.74
loading
Schlusskurs vom Vortag:
$325.18
Offen:
$327.23
24-Stunden-Volumen:
3.48M
Relative Volume:
2.78
Marktkapitalisierung:
$64.53B
Einnahmen:
$325.78B
Nettoeinkommen (Verlust:
$1.64B
KGV:
39.90
EPS:
8.3139
Netto-Cashflow:
$3.61B
1W Leistung:
-5.93%
1M Leistung:
-7.62%
6M Leistung:
+14.39%
1J Leistung:
+24.80%
1-Tages-Spanne:
Value
$325.90
$334.09
1-Wochen-Bereich:
Value
$318.12
$356.08
52-Wochen-Spanne:
Value
$264.33
$377.54

Cencora Inc Stock (COR) Company Profile

Name
Firmenname
Cencora Inc
Name
Telefon
610-727-7000
Name
Adresse
1 WEST FIRST AVENUE, CONSHOHOCKEN
Name
Mitarbeiter
51,000
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
COR's Discussions on Twitter

Compare COR vs MCK, CAH, HSIC, AHG

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Distribution icon
COR
Cencora Inc
331.74 63.26B 325.78B 1.64B 3.61B 8.3139
Medical Distribution icon
MCK
Mckesson Corporation
898.95 112.73B 397.96B 4.55B 9.64B 34.77
Medical Distribution icon
CAH
Cardinal Health Inc
210.92 49.86B 244.67B 1.68B 5.51B 6.9487
Medical Distribution icon
HSIC
Henry Schein Inc
72.68 8.39B 13.18B 419.00M 521.00M 3.2704
Medical Distribution icon
AHG
Akso Health Group Adr
2.42 2.09B 14.85M -136.07M 7.23M -0.4726

Cencora Inc Stock (COR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2026-01-29 Hochstufung Morgan Stanley Equal-Weight → Overweight
2026-01-22 Hochstufung Jefferies Hold → Buy
2025-12-09 Eingeleitet Barclays Overweight
2025-06-03 Hochstufung Wells Fargo Equal Weight → Overweight
2024-12-04 Fortgesetzt Mizuho Outperform
2024-09-18 Herabstufung BofA Securities Buy → Neutral
2024-02-26 Eingeleitet Leerink Partners Outperform
2024-01-03 Eingeleitet Barclays Overweight
2023-12-14 Eingeleitet Wells Fargo Equal Weight
2023-03-31 Eingeleitet Citigroup Buy
2023-01-31 Fortgesetzt Evercore ISI Outperform
2022-10-11 Hochstufung BofA Securities Neutral → Buy
2022-08-22 Fortgesetzt Morgan Stanley Equal-Weight
2022-07-11 Herabstufung Evercore ISI Outperform → In-line
2022-06-07 Hochstufung Deutsche Bank Hold → Buy
2022-05-26 Hochstufung Barclays Equal Weight → Overweight
2022-04-12 Herabstufung Morgan Stanley Overweight → Equal-Weight
2022-04-01 Fortgesetzt Credit Suisse Outperform
2021-03-12 Fortgesetzt Evercore ISI In-line
2021-02-04 Hochstufung Evercore ISI In-line → Outperform
2021-02-02 Hochstufung Cowen Market Perform → Outperform
2021-01-06 Hochstufung BofA Securities Underperform → Neutral
2021-01-06 Hochstufung Credit Suisse Neutral → Outperform
2020-12-10 Herabstufung Wells Fargo Equal Weight → Underweight
2020-12-03 Eingeleitet Mizuho Neutral
2020-08-06 Hochstufung Raymond James Mkt Perform → Outperform
2020-07-15 Eingeleitet Barclays Underweight
2020-06-15 Hochstufung Morgan Stanley Equal-Weight → Overweight
2020-04-23 Fortgesetzt Credit Suisse Outperform
2020-04-16 Herabstufung Raymond James Outperform → Mkt Perform
2020-04-13 Herabstufung Robert W. Baird Outperform → Neutral
2020-04-01 Hochstufung JP Morgan Neutral → Overweight
2020-03-17 Hochstufung Citigroup Neutral → Buy
2020-02-11 Herabstufung BofA/Merrill Buy → Underperform
2020-02-07 Hochstufung Robert W. Baird Neutral → Outperform
2019-09-12 Eingeleitet Deutsche Bank Hold
2019-07-10 Herabstufung KeyBanc Capital Markets Overweight → Sector Weight
2019-04-11 Eingeleitet Guggenheim Buy
2019-04-10 Herabstufung BofA/Merrill Buy → Underperform
2019-04-10 Herabstufung Evercore ISI Outperform → In-line
2019-02-11 Herabstufung JP Morgan Neutral → Underweight
2019-01-17 Eingeleitet UBS Buy
2018-12-10 Herabstufung Jefferies Buy → Hold
2018-10-26 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2018-09-20 Eingeleitet Berenberg Buy
2018-07-17 Fortgesetzt Stifel Hold
2018-04-09 Eingeleitet MoffettNathanson Buy
2018-03-12 Hochstufung KeyBanc Capital Mkts Sector Weight → Overweight
2018-03-12 Hochstufung Raymond James Mkt Perform → Outperform
2017-09-25 Eingeleitet JP Morgan Neutral
2017-09-22 Eingeleitet William Blair Outperform
Alle ansehen

Cencora Inc Aktie (COR) Neueste Nachrichten

pulisher
04:35 AM

Cencora, Inc. $COR Position Lessened by CIBC Private Wealth Group LLC - MarketBeat

04:35 AM
pulisher
03:11 AM

A Look At Cencora (COR) Valuation After Recent Share Price Weakness - simplywall.st

03:11 AM
pulisher
Mar 18, 2026

Cencora Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

Mar 18, 2026
pulisher
Mar 18, 2026

Cencora, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo

Mar 18, 2026
pulisher
Mar 18, 2026

COR's MWI Animal Health to merge with Covetrus in $3.5 billion deal - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Cencora Releases Fiscal Year 2025 Corporate Responsibility Report, Marking 10 Years of Purpose in Action - CSRwire

Mar 18, 2026
pulisher
Mar 18, 2026

CENCORA INC (NYSE:COR) Passes the "Caviar Cruise" Quality Investing Screen - ChartMill

Mar 18, 2026
pulisher
Mar 18, 2026

Cencora, Inc. Hits Day Low of $329.03 Amid Price Pressure - Markets Mojo

Mar 18, 2026
pulisher
Mar 18, 2026

305,934 Shares in Cencora, Inc. $COR Bought by Danske Bank A S - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Silvant Capital Management LLC Decreases Stock Holdings in Cencora, Inc. $COR - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Livforsakringsbolaget Skandia Omsesidigt Buys 54,700 Shares of Cencora, Inc. $COR - MarketBeat

Mar 18, 2026
pulisher
Mar 18, 2026

Cencora CFO James Cleary to retire, reaffirms 2026 guidance By Investing.com - Investing.com South Africa

Mar 18, 2026
pulisher
Mar 17, 2026

Maintained: Leerink, Evercore Outperform; BofA Neutral on Cencora COR March 2026 - Meyka

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora, Inc. (COR) Announces CFO Retirement and Reaffirms Earni - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

A4EQAB Bond Risk Analysis - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

A4EQAB Bond Coupon Analysis — Rate & Payments - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Here's why you should hold Cencora stock in your portfolio for now - MSN

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora (COR) Announces CFO Transition with Cleary's Retirement - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

A4EQAB Bond Analysis — Key Metrics - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Here’s Why Keeping Cencora Shares in Your Portfolio Makes Sense Right Now - Bitget

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora Inc (COR) Shares Gap Down to $333.68 on Mar 17 - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

A4EQAB Bond Price and Chart — GETTEX:A4EQAB - TradingView

Mar 17, 2026
pulisher
Mar 17, 2026

Here's Why You Should Hold Cencora Stock in Your Portfolio for Now - Yahoo Finance

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora CFO announces retirement - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora shares may face pressure as CFO Cleary to retire - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora stock rating held at Neutral by BofA on growth outlook - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora (COR) Reaffirms Fiscal Year 2026 Earnings Guidance - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora Announces CFO Transition as James F. Cleary Retires; Reaffirms 2026 Financial Guidance - Minichart

Mar 17, 2026
pulisher
Mar 17, 2026

Evercore ISI maintains Cencora stock rating on CFO transition By Investing.com - Investing.com South Africa

Mar 17, 2026
pulisher
Mar 17, 2026

Evercore ISI maintains Cencora stock rating on CFO transition - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora (COR) CFO to Retire in 2026, Company Reaffirms EPS Guida - GuruFocus

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora, Inc. Announces Retirement of James F. Cleary as Executive Vice President, Effective June 30, 2026 - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora CFO James Cleary to retire, reaffirms 2026 guidance - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora CFO James F. Cleary To Retire - citybiz

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora CFO Retirement Announced, Financial Guidance Reaffirmed - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

[8-K] Cencora, Inc. Reports Material Event | COR SEC FilingForm 8-K - Stock Titan

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora Announces Financial Leadership Transition - ChartMill

Mar 17, 2026
pulisher
Mar 17, 2026

LRT Capital Management LLC Lowers Stock Holdings in Cencora, Inc. $COR - MarketBeat

Mar 17, 2026
pulisher
Mar 17, 2026

Cencora Inc. Stock (ISIN: US15135B1017) Holds Steady Amid Healthcare Distribution Resilience - AD HOC NEWS

Mar 17, 2026
pulisher
Mar 16, 2026

Market Leaders: Is Cencora Inc subject to activist investor interestWeekly Investment Summary & Smart Swing Trading Alerts - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

Cencora Inc. stock underperforms Monday when compared to competitors - MarketWatch

Mar 16, 2026
pulisher
Mar 16, 2026

Earnest Partners LLC Reduces Position in Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

CSM Advisors LLC Sells 13,711 Shares of Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Chevy Chase Trust Holdings LLC Buys 7,835 Shares of Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

California Public Employees Retirement System Has $184.01 Million Stock Holdings in Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Bank of Nova Scotia Grows Position in Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 16, 2026

Alliancebernstein L.P. Has $278.09 Million Stake in Cencora, Inc. $COR - MarketBeat

Mar 16, 2026
pulisher
Mar 15, 2026

Clark Capital Management Group Inc. Increases Stock Position in Cencora, Inc. $COR - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

Cencora, Inc. (NYSE:COR) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat

Mar 15, 2026
pulisher
Mar 14, 2026

Wellington Management Group LLP Has $1.24 Billion Stake in Cencora, Inc. $COR - MarketBeat

Mar 14, 2026

Finanzdaten der Cencora Inc-Aktie (COR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
medical_distribution CAH
$210.92
price down icon 0.45%
medical_distribution MCK
$898.95
price down icon 2.33%
$72.68
price down icon 0.60%
medical_distribution AHG
$2.42
price down icon 0.82%
medical_distribution ACH
$2.03
price down icon 10.57%
Kapitalisierung:     |  Volumen (24h):